LUM and breast cancer: Moreover, lumican achieved a striking decrease of the proteolytic activity of MMP-14 both in the highly-invasive MCF-7/SP10+ and in the aggressive MDA-MB-231 cells, rendering lumican as a critical inhibitor of breast cancer invasion and metastasis.